The 2023 guideline on managing muscle-invasive bladder cancer offers evidence-based recommendations, but clinicians should rely on their expertise when making treatment decisions for individual patients. The 2023 EAU guideline on muscle-invasive (MIBC) bladder cancer updates surgery, bladder preservation, chemotherapy, and immunotherapy.